Savient Pharmaceuticals reports gout drug manufacturing problems
Following the batch failures, the company released a statement indicating the problems are within normal industry failure rates experienced for the commencement of biologic commercial manufacturing. The offending
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.